Literature DB >> 18255045

Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients.

Soon-Phaik Chee1, Kristine Bacsal, Aliza Jap, Su-Yun Se-Thoe, Ching Li Cheng, Ban Hock Tan.   

Abstract

PURPOSE: To describe the clinical presentation of cytomegalovirus (CMV) anterior uveitis in human immunodeficiency virus (HIV)-negative patients.
DESIGN: Retrospective, interventional case series.
METHODS: HIV-negative patients with anterior uveitis associated with elevated intraocular pressure (hypertensive anterior uveitis) seen at the Singapore National Eye Centre had their aqueous analyzed for viral deoxyribonucleic acid by polymerase chain reaction, and their records were reviewed for demographic data, ocular findings, laboratory results, and treatment.
RESULTS: Aqueous was obtained from 105 of 106 eligible eyes. Twenty-four eyes demonstrated positive results for CMV (22.8%). Eighteen eyes had Posner-Schlossman syndrome (PSS; 75%) at presentation, five eyesba had Fuchs heterochromic iridocyclitis (FHI; 20.8%), and one eye had a presumed herpetic anterior uveitis. Twelve of the 24 eyes were treated with ganciclovir. Of the 12 who completed treatment, all responded clinically, and their aqueous demonstrated negative results for CMV on repeat testing. However, nine had recurrences within eight months of stopping treatment and required further courses of ganciclovir. The 81 CMV-negative eyes included 30 with PSS, 11 with FHI, 27 with uveitic glaucomas of unknown cause, and 13 with presumed herpetic anterior uveitis.
CONCLUSIONS: CMV anterior uveitis is not uncommon in our immunocompetent patients and it may present as a recurrent acute or chronic inflammation, resembling PSS, herpetic anterior uveitis, or FHI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255045     DOI: 10.1016/j.ajo.2007.12.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  86 in total

1.  Unexplained Anterior Uveitis: Viral Causes.

Authors:  Keerti Mundey; Ishfaq Ahmad Sofi
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Eighteen months of anterior chamber inflammation.

Authors:  Vishal Jhanji; Rachel Kwok; Alvin L Young
Journal:  BMJ Case Rep       Date:  2013-08-30

3.  Clinical features of anterior uveitis caused by three different herpes viruses.

Authors:  Jun-Ichi Sakai; Yoshihiko Usui; Jun Suzuki; Takeshi Kezuka; Hiroshi Goto
Journal:  Int Ophthalmol       Date:  2019-05-27       Impact factor: 2.031

4.  Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation.

Authors:  Michiko Kandori; Dai Miyazaki; Keiko Yakura; Naoki Komatsu; Chizu Touge; Ryoko Ishikura; Yoshitsugu Inoue
Journal:  Jpn J Ophthalmol       Date:  2013-08-09       Impact factor: 2.447

Review 5.  [Fuchs uveitis].

Authors:  L Daas; B Seitz; U Pleyer
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

6.  Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus.

Authors:  Hiroshi Takase; Reo Kubono; Yukiko Terada; Ayano Imai; Shoko Fukuda; Makoto Tomita; Masaru Miyanaga; Koju Kamoi; Sunao Sugita; Kazunori Miyata; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2014-08-16       Impact factor: 2.447

7.  Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome.

Authors:  B Sobolewska; C Deuter; D Doycheva; M Zierhut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-28       Impact factor: 3.117

8.  Infectious Uveitis.

Authors:  Phoebe Lin
Journal:  Curr Ophthalmol Rep       Date:  2015-06-13

9.  Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay.

Authors:  Nadia Bouchenaki; Carl P Herbort
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

10.  Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs' heterochromic cyclitis.

Authors:  Peter C Ruokonen; Sylvia Metzner; Aylin Ucer; Necip Torun; Jörg Hofmann; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.